ATE27822T1 - Hexapeptid, verfahren zur herstellung und pharmazeutische zusammensetzungen hieraus. - Google Patents

Hexapeptid, verfahren zur herstellung und pharmazeutische zusammensetzungen hieraus.

Info

Publication number: ATE27822T1
Authority: AT; Austria
Prior art keywords: hexapeptide; processes; preparation; pharmaceutical compositions; pro
Prior art date: 1984-02-07

Application number

AT85400168T

Other languages

English (en)

Inventor

Pierre Jolles

Daniele Migliore-Samour

Fabienne Parker

Monika Casaretto

Original Assignee

Inst Nat Sante Rech Med

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-02-07

Filing date

1985-02-01

Publication date

1987-07-15

1985-02-01 Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med

1987-07-15 Application granted granted Critical

1987-07-15 Publication of ATE27822T1 publication Critical patent/ATE27822T1/de

Links

239000008194 pharmaceutical composition Substances 0.000 title 1
ZQOILFFBJUNGRA-NMVUUJPQSA-N (4s)-4-[[(2s)-2-amino-3-methylbutanoyl]amino]-5-[(2s)-2-[[(2s,3s)-1-[(2s)-2-[[(1s)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-5-oxopentanoic acid Chemical compound N([C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)C(C)C ZQOILFFBJUNGRA-NMVUUJPQSA-N 0.000 abstract 1
125000000539 amino acid group Chemical group 0.000 abstract 1
239000005018 casein Substances 0.000 abstract 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract 1
235000021240 caseins Nutrition 0.000 abstract 1
230000007062 hydrolysis Effects 0.000 abstract 1
238000006460 hydrolysis reaction Methods 0.000 abstract 1
230000001900 immune effect Effects 0.000 abstract 1
108010030651 valyl-glutamyl-prolyl-isoleucyl-prolyl-tyrosine Proteins 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

AT85400168T 1984-02-07 1985-02-01 Hexapeptid, verfahren zur herstellung und pharmazeutische zusammensetzungen hieraus. ATE27822T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR8401816A FR2559157B1 (fr)	1984-02-07	1984-02-07	Nouvel hexapeptide, son procede d'obtention et les compositions pharmaceutiques qui le contiennent
EP85400168A EP0155199B1 (de)	1984-02-07	1985-02-01	Hexapeptid, Verfahren zur Herstellung und pharmazeutische Zusammensetzungen hieraus

Publications (1)

Publication Number	Publication Date
ATE27822T1 true ATE27822T1 (de)	1987-07-15

Family

ID=9300812

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT85400168T ATE27822T1 (de)	1984-02-07	1985-02-01	Hexapeptid, verfahren zur herstellung und pharmazeutische zusammensetzungen hieraus.

Country Status (7)

Country	Link
US (1)	US4637997A (de)
EP (1)	EP0155199B1 (de)
JP (1)	JPS60188399A (de)
AT (1)	ATE27822T1 (de)
CA (1)	CA1250810A (de)
DE (1)	DE3560262D1 (de)
FR (1)	FR2559157B1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0680014B2 (ja) *	1985-12-10	1994-10-12	雪印乳業株式会社	低分子ペプチドを有効成分とする免疫賦活剤及びその調製法
DE3736589A1 (de) *	1987-10-29	1989-05-11	Behringwerke Ag	Glutaminhaltige peptide, verfahren zu deren herstellung und verwendung
DE69423243T2 (de) *	1994-05-12	2000-11-02	Orsolya Csuka	Stoffe zur aufhebung von arzneimittelresistenzen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3558770A (en) *	1967-09-01	1971-01-26	Kraftco Corp	Wound treating composition employing an enzyme modified casein
FR2491334A1 (fr) *	1980-10-03	1982-04-09	Inst Nat Sante Rech Med	Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant
FR2513881A2 (fr) *	1980-10-03	1983-04-08	Inst Nat Sante Rech Med	Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant

1984
- 1984-02-07 FR FR8401816A patent/FR2559157B1/fr not_active Expired
1985
- 1985-02-01 EP EP85400168A patent/EP0155199B1/de not_active Expired
- 1985-02-01 DE DE8585400168T patent/DE3560262D1/de not_active Expired
- 1985-02-01 AT AT85400168T patent/ATE27822T1/de not_active IP Right Cessation
- 1985-02-04 US US06/697,903 patent/US4637997A/en not_active Expired - Fee Related
- 1985-02-05 JP JP60019373A patent/JPS60188399A/ja active Pending
- 1985-02-06 CA CA000473682A patent/CA1250810A/fr not_active Expired

Also Published As

Publication number	Publication date
EP0155199A1 (de)	1985-09-18
US4637997A (en)	1987-01-20
EP0155199B1 (de)	1987-06-16
FR2559157A1 (fr)	1985-08-09
CA1250810A (fr)	1989-03-07
JPS60188399A (ja)	1985-09-25
FR2559157B1 (fr)	1986-08-01
DE3560262D1 (en)	1987-07-23

Similar Documents

Publication	Publication Date	Title
DE69111175D1 (de)	1995-08-17	Verfahren zur Herstellung modifizierter proteinischer Produkte und Zusammensetzungen daraus.
EP1440980A3 (de)	2005-01-19	Peptidanaloge des menschlichen, basischen Myelinproteins
AU6020099A (en)	2000-03-14	Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
WO2000053758A3 (en)	2001-02-08	Compositions and methods for the treatment of immune related diseases
EP0911390A3 (de)	2003-02-26	Protein-Kinases als Werkzeuge zur Diagnose und Behandlung von Alzheimer's Krankheit
IL112585A (en)	2000-08-31	N-terminally chemically modified G-CSF and analogs process for their preparation and pharmaceutical compositions containing them
ATE108662T1 (de)	1994-08-15	Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
WO2000073452A3 (en)	2001-06-28	Compositions and methods for the treatment of immune related diseases
DE69129899D1 (de)	1998-09-03	Verfahren zur Herstellung von D-Alpha-Aminosäuren
WO1996028470A3 (en)	1996-11-14	Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
ATE213499T1 (de)	2002-03-15	Peptidanaloge des menschlichen, basischen myelinproteins mit substitution an position 91 zur behandlung der multiplen sklerose
DE3462039D1 (en)	1987-02-19	Peptide derivatives, their preparation and use as elastase inhibitors
AU4011300A (en)	2001-02-05	Compositions and methods for the treatment of immune related diseases
WO1999014241A3 (en)	1999-06-10	Compositions and methods for the treatment of immune related diseases
ES548052A0 (es)	1987-02-16	Procedimiento para preparar peptidos
DE69010294D1 (de)	1994-08-04	Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs.
DE59004490D1 (de)	1994-03-17	Verfahren zur Herstellung von alpha-Fluoracrylsäurederivaten.
HUT52117A (en)	1990-06-28	Process for producing amblyommin and process for producing pharmaceutical compositions comprising such compound as active ingredient
WO2001040465A3 (en)	2002-03-21	Compositions and methods for the treatment of immune related diseases
DE3560262D1 (en)	1987-07-23	Hexapeptide, process for its preparation and pharmaceutical compositions thereof
DE69018079D1 (de)	1995-04-27	Verfahren zur Herstellung wässriger beladener Latexzusammensetzungen.
DE69013621D1 (de)	1994-12-01	Verfahren zur Herstellung von tertiärem Amino-Alkohol.
WO2000015797A3 (en)	2000-08-24	Compositions and methods for the treatment of immune related diseases
DE69327279D1 (de)	2000-01-20	Verfahren zur Herstellung von Zusammensetzungen für Wiederkäuer
DE58908978D1 (de)	1995-03-23	Verfahren zur Herstellung von Pigmentzusammensetzungen.

Legal Events

Date	Code	Title	Description
1987-11-15	UEP	Publication of translation of european patent specification
1992-11-15	REN	Ceased due to non-payment of the annual fee